Moderna asks FDA to allow vaccine for ages 12-17

The Philippine Food and Drug Administration (FDA) is studying whether to amend Moderna’s emergency use authorization (EUA) COVID-19 in adolescents ages 12 and older.

FDA director-general Eric Domingo said U.S. vaccine developer Moderna had already applied on Aug. 19, 2021.

ADVERTISEMENT

The FDA is expected to complete an evaluation of clinical data submitted by Moderna this week or next week.

If approved, Moderna will be the second to be used by 12 to 17-year-olds.

In June, the FDA approved the use of the Pfizer-BioNTech vaccine for ages 12-15.

ADVERTISEMENT

However, if Moderna gets approval, he said, it still does not mean that the aforementioned ages will be vaccinated immediately because the government still gives more priority to adult priority groups belonging to senior citizens, persons with comorbidities,
medical frontliners, and economic frontliners who are more vulnerable and more exposed to COVID-19.

Meanwhile, the FDA has not yet approved the Chinese vaccine maker Sinovac to allow vaccination against 3-17-year-olds because only a few of these age groups were included in clinical studies.

Early this month, the group of Filipino-Chinese Businessmen, the Federation of Filipino Chinese Chambers of Commerce and Industry, also plans to buy Pfizer or Sinovac vaccines given to children.

ADVERTISEMENT

Moderna asks FDA to allow vaccine for ages 12-17

“Sa amin, walang sinisingil, laging kawanggawa… Alam nyo po tayo nasa isang bansa, kung ano mangyari apektado kapwa natin, kung ano mangyari sa mga bata, apektado mga magulang di makatrabaho,” said their leader Amb. Francis Chua.

Experts noted that the number of COVID-19 cases among young people is increasing.

Meanwhile, it will not be long before the  by Pfizer – BioNTech can be sold commercially in the Philippines if the Palace is asked.

This was stated by presidential spokesperson Harry Roque, Tuesday. The US Food and Drug Administration (US FDA) has given full approval to the said  brand for 16-years and above.

“Bagama’t kinakailangan bigyan pa rin ng commercial use approval ng Philippine FDA ang Pfizer, ito po’y mapapabilis dahil meron tayong polisiya na ang Philippine FDA ay mas mabilis naaaprubahan for commercial use ang mga bakuna’t gamot na meron nang approval sa mga stringent na FDAs gaya po ng Estados Unidos,” said Roque.

Visit our Facebook page for more  updates.